PF-Atlas › Clinical Trials › NCT07685938

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

Atorvastatin and Lisinopril · Phase 2

Registry ID
NCT07685938
Phase
Phase 2
Status
Not yet recruiting
Drug / intervention
Atorvastatin and Lisinopril
Sponsor
UNC Lineberger Comprehensive Cancer Center
Start
2026-07

About this trial

Atorvastatin and Lisinopril is evaluated in NCT07685938, a Phase 2 idiopathic pulmonary fibrosis study sponsored by UNC Lineberger Comprehensive Cancer Center. Current status: Not yet recruiting.

View NCT07685938 on ClinicalTrials.gov →

Explore related

All Atorvastatin and Lisinopril trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT07685938 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.